Eli Lilly's (LLY) Reaction to Disappointing Evacetrapib Data Appears 'Overdone', Says BofA/ML
Go back to Eli Lilly's (LLY) Reaction to Disappointing Evacetrapib Data Appears 'Overdone', Says BofA/ML| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1168.39 +15.46 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.93 | 52 Week High | $88.16 | |||
| Open | $1144.50 | 52 Week Low | $67.88 | |||
| Day High | $1170.90 | P/E | 270.46 | |||
| Day Low | $1134.41 | EPS | $4.32 | |||
| Volume | 1,084,708 | |||||

